搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
29 分钟
Lilly Alzheimer's drug not to be covered by U.K.'s NHS: report
U.K. regulators will reportedly recommend the NHS not cover Eli Lilly’s (LLY) donanemab for the treatment of early ...
BBC
53 分钟
New hope for rapid dementia diagnosis
"By the time the symptoms of dementia and other neurological diseases appear it is already too late," said Prof Sumeet ...
1 小时
on MSN
Decision expected on new Alzheimer’s treatment
The drug, and another new drug for Alzheimer’s called lecanemab, have been billed as a huge step forward in research because ...
2 小时
Alzheimer’s wonder drug faces NHS block over cost
The most effective drug for Alzheimer’s will be blocked for use on the NHS on Wednesday. Regulators are expected to declare ...
3 小时
UK's NHS to block Eli Lilly's Alzheimer's drug on Wednesday, Telegraph reports
Britain's National Health Service (NHS) will block Eli Lilly's Alzheimer's drug donanemab on Wednesday, deeming it too ...
restless
4 小时
10 foods that may reduce the risk of Alzheimer’s disease
Alzheimer’s disease is the leading cause of dementia in the UK. It’s a complex, challenging, and devastating condition that causes a gradual decline in a person’s cognition, including memory and ...
5 小时
Why thousands of dementia sufferers are being denied the new miracle drug
In late 2022, the results of a groundbreaking stage three trial for a ‘miracle’ new Alzheimer’s drug lecanemab were hailed as ...
5 小时
Photomicrography contest winners showcase beauty at tiny scales
Nikon Small World photomicrography contest is an annual reminder that science can be beautiful as well as informative.
6 小时
Study highlights complexity of menopausal hormone therapy's impact on brain health
A study suggests that menopausal hormone therapy (MHT) might have moderate effects on brain health, but this depends on past ...
BioSpace
6 小时
Roche Trims Another Alzheimer’s Prospect, Ending UCB Collabortion
Roche drops a third Alzheimer’s candidate this year, terminating a partnership with UCB just four years after agreeing to ...
The American Journal of Managed Care
6 小时
Undiagnosed Cognitive Issues Widespread in Federally Qualified Health Centers
A study in Indiana found that older adults in low-income clinics often experience memory problems that go undetected, with ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈